文献速递淋巴瘤

脾边缘区淋巴瘤脾切除患者生存更优:瑞典人群研究

Superior outcome for splenectomised patients in a population-based study of splenic marginal zone lymphoma in Sweden.
PubMed 文献 · Br J Haematol · 2021-06-09

瑞典2007-2017年淋巴瘤登记中277例脾边缘区淋巴瘤患者,30%有自身免疫炎症病史,2%有病毒性肝炎史;

要点

  • SMZL患者中自身免疫炎症病史常见(30%),病毒性肝炎少见(2%)。
  • Upfront脾切除与显著更优的总生存和无进展生存相关。
  • 病毒性肝炎和自身免疫病史不影响SMZL结局。

核心结论

  • 在瑞典SMZL人群中,upfront脾切除与更优的总生存和无进展生存相关。

研究设计与样本

  • 基于瑞典淋巴瘤登记的人群研究,纳入2007-2017年277例SMZL患者。

主要发现

  • 5例(2%)报告病毒性肝炎病史,72/240例(30%)诊断前有自身免疫炎症疾病史。
  • 207例(75%)接受upfront治疗,其中119例(57%)行脾切除(伴或不伴全身治疗)。
  • 病毒性肝炎和自身免疫炎症病史不影响SMZL结局。

关键数值与推荐

  • 脾切除组更年轻、Ann Arbor分期总体更低,但B症状和高乳酸脱氢酶更常见。

临床怎么用

  • 对适合的SMZL患者,upfront脾切除可作为改善生存的治疗选择。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Splenic marginal zone lymphoma (SMZL) is a rare low-grade B-cell lymphoma where associations with viral hepatitis and autoimmune and inflammatory diseases (AID) have been indicated. We aimed at assessing the prevalence of viral hepatitis and AID at SMZL diagnosis and outcome by treatment in a Swedish population-based study. A total of 277 SMZL patients registered in the Swedish Lymphoma Register in 2007-2017 were included. A history of viral hepatitis was reported in five (2%) patients and AID prior to SMZL in 72/240 (30%) patients. Treatment was given up front for 207 (75%) patients. Splenectomy with or without systemic treatment was performed in 119 (57%) and was associated with statistically significantly better overall survival [hazard ratio, HR = 0·47 (95% confidence interval, CI: 0·23-0·93), P = 0·03] and progression-free survival (HR = 0·55, 95% CI: 0·35-0·86, P = 0·008) compared to non-splenectomised patients in multivariable analyses. The up-front splenectomised group was younger and generally had a lower Ann Arbor stage, but also more frequently B symptoms and high lactate dehydrogenase than the non-splenectomised group. Viral hepatitis and AID history did not affect SMZL outcome. We report high incidence of AIDs and low incidence of viral hepatitis in this population-based study of SMZL. Splenectomy up front was associated with a favourable outcome.

来源:Br J Haematol,查看原文。版权归原作者所有。

引用

  1. Sima A, Hollander P, Baecklund E, et al. Superior outcome for splenectomised patients in a population-based study of splenic marginal zone lymphoma in Sweden. Br J Haematol. 2021. PMID: 34109612. doi:10.1111/bjh.17577

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。